Attrition in drug discovery and development remains a major challenge. Safety/toxicity is the most prevalent reason for failure with cardiovascular and CNS toxicities predominating. Non-invasive biomarkers of neurotoxicity would provide significant advantage by allowing earlier prediction of likely neurotoxicity in ...
Drug Discovery and Development: Biomarkers of Neurotoxicity and Neurodegeneration
Experimental Biology and Medicine, 2018